COPD

Assessing Exercise Techniques in Pulmonary Rehabilitation for COPD

By

Tori Rodriguez, MA, LPC, AHC

Pulmonary rehabilitation programs represent a key component in the management of patients with chronic obstructive pulmonary disease.

COPD-Related Cognitive Impairment Unlike Other Forms of Dementia

By

Tori Rodriguez, MA, LPC, AHC

The prevalence of cognitive impairment is higher in patients with COPD compared with healthy individuals.

Could Vascular Dysfunction Be a Primary vs Secondary Feature of COPD?

By

Pulmonology Advisor Contributing Writer

New research suggests chronic obstructive pulmonary disease directly caused by tobacco smoke could be cured.

Pulmonary Rehabilitation May Improve Quality of Life in COPD

By

Bryant Moeller

Patients with chronic obstructive pulmonary disease showed lasting improvements for up to 2 years in anxiety and quality of life following 8 weeks of pulmonary rehabilitation.

COPDCompEx May Predict Treatment Effect on COPD Exacerbations

By

Sheila Jacobs

Use of the novel composite end point known as COPDCompEx may be able to predict treatment effect on moderate to severe exacerbations of COPD, thus allowing shorter phase 2 clinical trials requiring fewer patients compared with current studies.

COPD Treatment May Increase Risk of Tuberculosis

By

Zahra Masoud

Fluticasone/salmeterol and budesonide/formoterol are common treatments for COPD; researchers investigated whether these treatments may be correlated with active tuberculosis risk.

ATS: Clinical Practice Guidelines on the Pharmacologic Management of COPD

By

Brandon May

The American Thoracic Society has released a new clinical practice guideline on the pharmacologic management of chronic obstructive pulmonary disease.

Acute COPD Exacerbation Frequency May Not Be Accurate Guide for Treatment

By

Bryant Moeller

The 12-month history of acute exacerbations used to guide most COPD treatment relies on an unstable frequent exacerbator phenotype.